Preparing For Off-Label Drug Use In The Real World (Part 1 Of 2)

Plans are acquiring the tools to monitor and assess the risk/benefit of drug use outside of the approved indication. Smart companies are working with payers to understand their concerns around off-label use and the data requirements in support of it.

More from Market Access

More from Pink Sheet